Experts Advise Caution and Holistic Approach for New ADHD Medication in Children

Attention Deficit Hyperactivity Disorder (ADHD) is a neurological condition affecting multiple aspects of life, not just academic performance. Ahead of the new school year, Dr. Steven Reingold and Dr. Dov Margalit emphasize a broad, science-based perspective on managing ADHD, focusing on the child's overall potential rather than solely on classroom behavior.

Modern medicine views the ADHD brain as functioning differently, characterized by a high demand for dopamine. The key to success lies in learning to manage this neurological 'superpower.' Digital overstimulation, especially misinformation on platforms like TikTok, worsens symptoms, highlighting the need to reduce digital noise.

Common myths about ADHD treatment are addressed: fears of addiction to medication are unfounded, as untreated dopamine deficiency can lead to risky self-medication; medications do not turn children into emotionless 'zombies,' and side effects like appetite suppression do not impact final adult height. Proper diagnosis requires validated questionnaires, clinical evaluation, and observation of symptoms in multiple settings before age 12.

ADHD symptoms evolve with age, often requiring ongoing medication review. Lifestyle factors such as good sleep, balanced breakfasts, and screen time limits are critical. Treatment should be holistic, combining medication with behavioral and emotional therapies.

Regarding new treatments, the recently FDA-approved drug "Symtrio" shows promise but lacks sufficient long-term studies, especially in children. Experts recommend cautious patience before adopting new medications, as existing treatments are effective and well-studied.

To ease the transition into the school year, parents should establish consistent routines, coordinate with healthcare providers, and communicate with teachers. Ultimately, the goal is to empower children with ADHD to harness their unique neurological strengths through informed, comprehensive care.